- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07096960
- Original Trial
Implementation of the START Intervention in Brazil: a Controlled Feasibility Trial (START/ESCADA)
A Brazilian Version of the STrAtegies for RelaTives (START) Intervention in the Unified Health System (SUS): a Controlled Feasibility Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will evaluate the feasibility of the START program in the Brazilian Unified Health System (SUS). The intervention was translated and culturally adapted through a structured process that included expert review and focus groups with mental health professionals and community general health workers (CGHW) to ensure the clarity and cultural relevance of the materials.
The intervention will be delivered by trained CGHW to family caregivers of people living with dementia. CGHW will undergo a 16-hour, in-person training provided by the research team. During the period of the intervention, they will receive ongoing remote supervision to support protocol adherence and address challenges encountered in the field.
Ten municipalities-two from each of the five geographical regions of Brazil-will participate. In each municipality, two primary care units (PCU) will be randomly allocated to either the intervention or the waitlist control group.
The selection of participating municipalities will be conducted in collaboration with each state's Bipartite Inter-managerial Commission (Comissão Intergestora Bipartite, CIB). Municipalities will be eligible if they have ≥100,000 inhabitants and agree to participate. Each will be required to list all PCU with ≥15 dementia diagnoses (ICD-10). If a municipality does not have at least two PCU meeting this threshold, units with ≥10 diagnoses may be considered. From this list, two PCU will be randomly drawn. Eligible pairs must meet two conditions: (1) they must be non-contiguous, and (2) their populations must be demographically similar, as assessed by local authorities. If these two criteria are not met, a new draw will be conducted.
Feasibility and acceptability will be assessed as primary outcomes through operational indicators (e.g., number of sessions completed, adherence, dropouts), structured online questionnaires completed by caregivers and CGHW, and semi-structured qualitative interviews conducted with caregivers, CGHW, and municipal health managers.
Secondary outcomes will include caregiver burden, mental health symptoms, quality of life, coping strategies, and neuropsychiatric symptoms of the care recipient. These outcomes will be measured at baseline and again six months after the intervention using validated instruments including the HADS, ZBI, WHOQOL-Bref, Brief COPE, and NPI.
Intervention fidelity will be assessed through randomly selected audio recordings of sessions and structured checklists completed by independent researchers.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lucas Martins Teixeira
- Phone Number: +55 86 999137014
- Email: lucas.martins@haoc.com.br
Study Locations
-
-
Espírito Santo
-
Vitória, Espírito Santo, Brazil
- Recruiting
- Lucas Martins Teixeira
-
Contact:
- Lucas M Teixeira
- Phone Number: +55 86 999137014
- Email: lucas.martins@haoc.com.br
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Informal caregivers (≥18 years old) who are the primary or one of the primary persons responsible for caring for a family member with dementia, providing regular and sustained emotional or practical support every week, and living in the same household or nearby with frequent face-to-face interaction.
- Care recipient (person with dementia) with Clinical Dementia Rating (CDR) score ≥1.
- Care recipient with at least one ICD-10 dementia diagnosis code documented in their medical record.
Exclusion criteria:
- Illiterate caregivers.
- Caregivers who provide only occasional or sporadic support (less than weekly or without regular caregiving responsibility).
- Care recipients who are institutionalized (e.g., living in long-term care facilities).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: START/ESCADA Intervention
Participants will receive the culturally adapted Brazilian version of START (ESCADA).
|
Eight individualized, weekly, home-based sessions will be delivered by trained community general health workers (CGHW).
The intervention includes coping strategies, behavior management, and communication skills.
Caregivers receive printed materials and structured exercises.
CGHW receive a facilitator manual.
|
|
No Intervention: Waitlist Control
Participants receive usual care and will be offered the START/ESCADA intervention after 6 months at the end of the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility questionnaire
Time Frame: Approximately 8 weeks post-baseline (after completing the intervention)
|
Feasibility of the START/ESCADA intervention assessed through an online structured questionnaire applied to caregivers and community health workers (CHW), covering domains of acceptability, demand, implementation, practicality, adaptation, integration, and expansion.
|
Approximately 8 weeks post-baseline (after completing the intervention)
|
|
Operational feasibility metrics
Time Frame: Approximately 8 weeks post-baseline (after completing the intervention)
|
Number of caregivers who consented to participate; number and proportion who completed all 8 sessions; average number of weeks to complete 8 sessions; number and proportion of community health workers (CHW) completing training; number of CHW delivering the intervention.
|
Approximately 8 weeks post-baseline (after completing the intervention)
|
|
Qualitative feasibility interviews
Time Frame: Approximately 8 weeks post-baseline (after completing the intervention)
|
Feasibility and acceptability of the START/ESCADA intervention assessed via semi-structured qualitative interviews with managers of primary care units, general health workers (ACS), and caregivers, exploring domains such as acceptability, demand, implementation, practicality, adaptation, integration, and expansion.
|
Approximately 8 weeks post-baseline (after completing the intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Caregiver burden
Time Frame: 6 months post-baseline
|
Zarit Burden Interview (ZBI), 22-item version; total score ranges from 0 to 88, with higher scores indicating greater caregiver burden.
|
6 months post-baseline
|
|
Anxiety and depression
Time Frame: 6 months post-baseline
|
Hospital Anxiety and Depression Scale (HADS); two subscales (Anxiety, Depression), each ranging from 0 to 21; higher scores indicate greater anxiety or depressive symptoms.
|
6 months post-baseline
|
|
Quality of life (caregiver)
Time Frame: 6 months post-baseline
|
World Health Organization Quality of Life Instrument - Short Form (WHOQOL-BREF); includes four domain scores (Physical Health, Psychological, Social Relationships, Environment), each transformed to a scale from 0 to 100; higher scores indicate better quality of life.
|
6 months post-baseline
|
|
Coping strategies
Time Frame: 6 months post-baseline
|
Brief COPE Inventory; 28 items grouped into 14 subscales (coping strategies), each subscale scored by summing two items (range 2 to 8); higher scores indicate greater use of the specific coping strategy.
|
6 months post-baseline
|
|
Neuropsychiatric symptoms
Time Frame: 6 months post-baseline
|
Neuropsychiatric Inventory (NPI); assesses 12 neuropsychiatric domains in dementia patients.
Each domain score is calculated by multiplying frequency (1-4) by severity (1-3), with domain scores ranging from 0 to 12.
The total NPI score ranges from 0 to 144, with higher scores indicating greater neuropsychiatric symptom burden.
|
6 months post-baseline
|
|
Use of health and social care resources
Time Frame: 6 months post-baseline
|
Structured questionnaire
|
6 months post-baseline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PC CEP HAOC 7.432.280
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Caregiver Burden of People With Dementia
-
Milton S. Hershey Medical CenterNYU Langone Health; National Institute on Aging (NIA)Not yet recruitingDementia | Caregiver Burden | Caregiver Stress | Caregiver Burden of People With DementiaUnited States
-
University of Southern CaliforniaCalifornia Department of Public HealthRecruitingCaregiver Burden of People With DementiaUnited States
-
University of RostockGerman Center for Neurodegenerative Diseases (DZNE)Completed
-
Hülya Nuray BayraktarHacettepe UniversityCompletedHealthy | Caregiver Burden | Self Efficacy | Caregiver | Caregiver Stress | Caregiver Burden of People With DementiaTurkey
-
The University of Hong KongFood and Health Bureau, Hong Kong; Lingnan UniversityNot yet recruitingDementia | Caregiver Burden of People With Dementia
-
China Medical University HospitalRecruitingCircadian Rhythm | Alzheimer's Dementia | Neuropsychiatric Symptoms Related to Neurodegenerative Disease | Wearable Devices | Caregiver Burden of People With DementiaTaiwan
-
Florida SouthWestern State CollegeStanford UniversityCompletedDementia | Cognitive Impairments | Alzheimer Disease (AD) | Depression Chronic | Caregiver Burden of People With DementiaUnited States
-
Instituto Nacional de Geriatria, MexicoNational Polytechnic Institute, Mexico; Universidad La Salle, MexicoCompletedDementia | Frailty | Music Therapy | Aged (80 or More) | Caregiver Burden of People With Dementia | Neuropsychiatric Symptom | Non-Pharmacological InterventionsMexico
-
Fatma Beyza AkdenizNot yet recruitingChildhood Cancer | Caregiver | Childhood Cancers | Caregiver Subjective Burden | Primary Caregivers of Children Newly Diagnosed With Cancer | Caregiver Anxiety | Caregiver Health Related QOL
-
The Wright InstituteRecruitingCaregiver Burden | Caregiver Stress Syndrome | Caregiver Burnout | Caregiver Awareness | Caregiver Stress | Caregiver Resilience and Stress | Caregiver Exhaustion | Caregiver Distress | Caregiver Health Related QOL | Caregiver Burden for Those Who Care for Adults With Impaired Functional Status | Caregiver... and other conditionsUnited States